Neuronal K(ATP) channels mediate hypoxic preconditioning and reduce subsequent neonatal hypoxic-ischemic brain injury

Hong-Shuo Sun1, Baofeng Xu2, Wenliang Chen2

  • 1Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

Experimental Neurology
|December 3, 2014
PubMed

Insights

Hypoxic preconditioning protects neonatal brains from injury by activating K(ATP) channels. This study shows K(ATP) channel openers could treat hypoxic-ischemic encephalopathy in newborns.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Cellular Physiology

Background:

  • Neonatal hypoxic-ischemic brain injury and encephalopathy cause significant neurological damage in children.
  • Hypoxic preconditioning (HPC) offers neuroprotection against cerebral ischemia, but the role of neuronal K(ATP) channels in this process remains unclear.
  • Understanding the mechanisms of HPC is crucial for developing effective treatments for neonatal brain injury.

Purpose of the Study:

  • To investigate the role of neuronal K(ATP) channels in hypoxic preconditioning (HPC)-mediated neuroprotection against hypoxia-ischemia (HI) induced brain injury in neonatal mice.
  • To determine if K(ATP) channel modulators can influence neuroprotection or neurodegeneration in this model.
  • To elucidate the molecular pathways involved in HPC-induced neuroprotection.

Main Methods:

  • Utilized a neonatal mouse model of hypoxic-ischemic (HI) brain injury.
  • Assessed infarct volume using 2,3,5-triphenyltetrazolium chloride (TTC) staining.
  • Quantified apoptotic cells via TUNEL staining and evaluated protein levels using Western blots.
  • Measured K(ATP) channel activity using patch-clamp recordings and assessed functional recovery through behavioral tests.

Main Results:

  • HPC significantly reduced infarct volume, decreased apoptotic cell death, and improved neurobehavioral outcomes in neonatal mice following HI.
  • Pharmacological manipulation of K(ATP) channels demonstrated their critical role: blockers (tolbutamide) abolished HPC's neuroprotection, while openers (diazoxide) mimicked it.
  • HPC upregulated Kir6.2, enhanced K(ATP) channel activity, restored PKC and pAkt levels, and reduced caspase-3 expression, effects inhibited by tolbutamide.

Conclusions:

  • Neuronal K(ATP) channels are integral to the neuroprotective effects of hypoxic preconditioning in neonatal hypoxic-ischemic brain injury.
  • K(ATP) channel openers represent a promising therapeutic strategy for treating neonatal hypoxic-ischemic brain injury and encephalopathy.